The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica The Peptide Craze Ground Truths Emerging Use of BPC 157 in Orthopaedic Sports Medicine: A Systematic Review Nikhil Vasireddi, Henrik Hahamyan, Michael J. Salata, Michael Karns, Jacob G. Calcei, James E. Voos, John M. Apostolakos, 2025 Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law